| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/22/2001 | CA2383927A1 Protein phosphatase and kinase proteins |
| 03/22/2001 | CA2383565A1 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | CA2383360A1 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | CA2383217A1 Lysosomal targeting pathway enzymes |
| 03/22/2001 | CA2383184A1 A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2383026A1 Combination treatment with il-1ra and compounds that inhibit il-1 processing and release |
| 03/22/2001 | CA2382633A1 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2377221A1 Hydroxyalkanoyl aminolactams and related structures as inhibitors of a.beta. protein production |
| 03/21/2001 | EP1085323A2 NADE binding proteins |
| 03/21/2001 | EP1085092A1 Phosphodiesterase enzymes |
| 03/21/2001 | EP1085014A1 1,5-benzodiazepine derivatives |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/21/2001 | EP1084719A1 Bone sialoprotein-based compositions for enhancing connective tissue repair |
| 03/21/2001 | EP1084270A1 Inhibition of coagulation in blood and blood products |
| 03/21/2001 | EP1084255A1 Tankyrase, a trf1 binding protein |
| 03/21/2001 | EP1084242A2 Phagocytic assay method |
| 03/21/2001 | EP1084147A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 03/21/2001 | EP1084146A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 03/21/2001 | EP1084143A1 Purification process for production of mannan-binding lectin and an mbl medicinal product |
| 03/21/2001 | EP1084137A1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 03/21/2001 | EP1084129A1 Cyclic boroproline compounds |
| 03/21/2001 | EP1084125A1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action |
| 03/21/2001 | EP1084123A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect |
| 03/21/2001 | EP1084122A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 03/21/2001 | EP1084119A1 Aromatic amine derivatives as pharmaceutical agents |
| 03/21/2001 | EP1084118A1 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4- 4-(4pyridyl) benzoyl] piperazine |
| 03/21/2001 | EP1084114A1 Isothiazole derivatives useful as anticancer agents |
| 03/21/2001 | EP1084113A1 A process for the preparation of macrocyclic metalloprotease inhibitors |
| 03/21/2001 | EP1084108A1 Spla 2? inhibitor compounds for treatment of disease |
| 03/21/2001 | EP1084104A1 Nitric oxide synthase inhibitors |
| 03/21/2001 | EP1084103A1 New 3-aryl-2-hydroxypropionic acid derivative (i) |
| 03/21/2001 | EP1083980A2 Modulation of molecular interaction sites on rna and other biomolecules |
| 03/21/2001 | EP1083934A2 Gene therapy method |
| 03/21/2001 | EP1083931A1 Stabilization of compositions containing ace inhibitors using magnesium oxide |
| 03/21/2001 | EP1083924A1 Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083913A1 Monoamine oxidase (mao) inhibitors and uses thereof |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083906A1 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue |
| 03/21/2001 | EP1083904A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 03/21/2001 | EP1083903A1 Bridged indenopyrrolocarbazoles |
| 03/21/2001 | EP1083899A1 METHOD OF ENHANCING LYSOSOMAL $g(a)-GALACTOSIDASE A |
| 03/21/2001 | EP1083898A1 Novel use of hiv protease inhibiting compounds |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083891A1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 03/21/2001 | EP1083890A1 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP1083877A1 N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses |
| 03/21/2001 | EP1083876A1 Small molecule sulfonamide hair growth compositions and uses |
| 03/21/2001 | EP1083875A1 Small molecule carbamate or urea hair growth compositions and uses |
| 03/21/2001 | EP1083874A1 Small molecule pipecolic acid derivative hair growth compositions and uses |
| 03/21/2001 | EP1083873A1 Heterocyclic thioester and ketone hair growth compositions and uses |
| 03/21/2001 | EP1083872A1 Pipecolic acid derivative hair growth compositions and uses |
| 03/21/2001 | EP0797678B1 Hybrid adenovirus-aav virus and method of use thereof |
| 03/21/2001 | EP0762877B1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof |
| 03/21/2001 | EP0717616B1 Process for conditioning substances |
| 03/21/2001 | EP0714284B1 Use of oligosaccharides for the prevention and treatment of tissue ageing |
| 03/21/2001 | CN1288467A Compounds with growth hormone releasing properties |
| 03/21/2001 | CN1288465A Triazolo-pyridzine derivatives as ligands for GABA receptors |
| 03/21/2001 | CN1288464A 4-(2-keto-1-benzimidazolynyl) pipeidine compounds as ORL-1 receptor |
| 03/21/2001 | CN1288458A Triazepinones, process for their prepn. and their therapeutic application |
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/21/2001 | CN1288385A Pharmaceutical formulations and processes for their prepn. |
| 03/21/2001 | CN1288382A Sea cucumber carotenoid lipid fraction products and method of use |
| 03/21/2001 | CN1288008A Sulfur-bearing phospho acid compound, pharmaceutical composite and use in prepn. of medicine |
| 03/21/2001 | CN1288007A 6-carbonyl-3-(4-[2-(pierid-1-yl)elhoyl]phenoxy)-2(4-methoxylphenyl) benzo[b]thiophene salt crystal |
| 03/21/2001 | CN1287838A Health-care products extracted from ostrich blood, penis orchis |
| 03/21/2001 | CN1063444C Stable crystalline (65)-and (GR)-tetrahydrofolic acid |
| 03/21/2001 | CN1063438C Alkenyl-benzoyl guanidine derivant, prepn. method and use thereof |
| 03/21/2001 | CN1063437C Fluorophenyl sbstd. alkenylc arboxylic acid guanidine its preparation method applied as medicine and diagnosis agent and medicine containing the compound |
| 03/21/2001 | CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof |
| 03/21/2001 | CN1063342C Haemorrhoidolysis powder |
| 03/20/2001 | US6204414 Intermediate compound (5-[2-hydroxy-5-(1-hydroxy-1-methylethyl)-2-methyl-cyclopentyl]-3-methyl-penta-2,4-dienyl) triphenylphos-phosphonium salt, for making metabolites of lycopene |
| 03/20/2001 | US6204364 Cell growth factor; for the treatment of cell proliferation and differentiation defects |
| 03/20/2001 | US6204362 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 03/20/2001 | US6204292 Bicyclic metabotropic glutamate receptor ligands |
| 03/20/2001 | US6204291 Effective amount of l-carnitine. |
| 03/20/2001 | US6204290 Treating a hypercholesteremic, thrombotic, oxidative, inflammatory, or immunoregulatory disease |
| 03/20/2001 | US6204280 Oxazolidinone derivative, anticoagulant |
| 03/20/2001 | US6204278 Anilide compounds, including use thereof in ACAT inhibitition |
| 03/20/2001 | US6204276 Dicarboxylic germanium complex and its therapeutic use |
| 03/20/2001 | US6204267 Methods of modulating serine/thereonine protein kinase function with quinazoline-based compounds |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204260 Non-peptidyl vasopressin V1a antagonists |
| 03/20/2001 | US6204259 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/20/2001 | US6204257 Drug delivery |
| 03/20/2001 | US6204247 Reacting a leptin with 0.5-5 fold molar excess of edta dianhydride to to form a monomer or dimer |
| 03/20/2001 | US6204055 Antisense inhibition of Fas mediated signaling |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204015 Aminopeptidase from staphylococcus aureus |
| 03/20/2001 | US6203995 Agouti-related transcript antibodies and methods of use |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203785 Poly(diallylamine)-based bile acid sequestrants |
| 03/20/2001 | CA2206287C Aryl thioxanthines |